|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5728553A
(en)
*
|
1992-09-23 |
1998-03-17 |
Delta Biotechnology Limited |
High purity albumin and method of producing
|
|
DE19538625C2
(de)
*
|
1995-10-17 |
1999-08-12 |
Sartorius Gmbh |
Verfahren zur Abtrennung von Albumin aus Serum durch Membranionenaustauschchromatographie
|
|
GB9526733D0
(en)
*
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
|
AU702567B2
(en)
*
|
1996-03-13 |
1999-02-25 |
Novozymes Biopharma Dk A/S |
Fermentation control
|
|
AU2007200859A1
(en)
*
|
1999-01-30 |
2007-03-22 |
Novozymes Delta Limited |
Process
|
|
GB9902000D0
(en)
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
|
WO2001077137A1
(en)
|
2000-04-12 |
2001-10-18 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
FR2792650B1
(fr)
*
|
1999-04-20 |
2003-02-28 |
Oreal |
Equivalent de peau agee, son procede de preparation et son utilisation
|
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
|
PT1398038E
(pt)
*
|
2000-02-08 |
2007-02-28 |
Allergan Inc |
Composições farmacêuticas de toxina botulínica
|
|
US20060269575A1
(en)
*
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
|
US8632785B2
(en)
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
US20050100991A1
(en)
*
|
2001-04-12 |
2005-05-12 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US6555543B2
(en)
|
2000-08-04 |
2003-04-29 |
Dmi Biosciences, Inc. |
Method of using diketopiperazines and composition containing them
|
|
JP4798833B2
(ja)
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
加熱処理工程を含むヒト血清アルブミンの製造方法
|
|
ES2261487T3
(es)
*
|
2000-10-24 |
2006-11-16 |
Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute |
Metodo de monomerizacion de polimeros de albumina de suero humano.
|
|
JP4798832B2
(ja)
*
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
ヒト血清アルブミン多量体の除去方法
|
|
US20050054051A1
(en)
*
|
2001-04-12 |
2005-03-10 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US7507413B2
(en)
*
|
2001-04-12 |
2009-03-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US20030036637A1
(en)
*
|
2001-06-13 |
2003-02-20 |
Scott Fulton |
Purification of human serum albumin
|
|
ITBO20010426A1
(it)
*
|
2001-07-06 |
2003-01-06 |
Alfa Wassermann Spa |
Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
|
|
JP2003040798A
(ja)
*
|
2001-07-26 |
2003-02-13 |
Nihon Pharmaceutical Co Ltd |
低アルミニウム含有アルブミン製剤およびその製造法
|
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
CA2471363C
(en)
*
|
2001-12-21 |
2014-02-11 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US20080167238A1
(en)
*
|
2001-12-21 |
2008-07-10 |
Human Genome Sciences, Inc. |
Albumin Fusion Proteins
|
|
CA2469435A1
(en)
*
|
2001-12-21 |
2003-07-24 |
X-Ceptor Therapeutics, Inc. |
Modulators of lxr
|
|
AU2002364587A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
GB0217033D0
(en)
|
2002-07-23 |
2002-08-28 |
Delta Biotechnology Ltd |
Gene and polypeptide sequences
|
|
NZ539735A
(en)
*
|
2002-10-02 |
2009-07-31 |
Dmi Biosciences Inc |
Diagnosis and monitoring of diseases using markers, such as diketopiperazines
|
|
CA2513213C
(en)
|
2003-01-22 |
2013-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
EP2799114A3
(en)
|
2003-05-15 |
2015-02-18 |
Ampio Pharmaceuticals, Inc. |
Treatment of T-cell mediated diseases
|
|
US7339347B2
(en)
*
|
2003-08-11 |
2008-03-04 |
Reserve Power Cell, Llc |
Apparatus and method for reliably supplying electrical energy to an electrical system
|
|
US8013611B2
(en)
*
|
2006-07-14 |
2011-09-06 |
Reserve Power Cell, Llc |
Vehicle battery product and battery monitoring system
|
|
GB0329722D0
(en)
*
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Modified plasmid and use thereof
|
|
GB0329681D0
(en)
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Gene expression technique
|
|
WO2005067960A1
(en)
*
|
2004-01-07 |
2005-07-28 |
Trimeris, Inc. |
HIV gp41 HR2-DERIVED SYNTHETIC PEPTIDES, AND THEIR USE IN THERAPY TO INHIBIT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS
|
|
CA2559379A1
(en)
|
2004-01-20 |
2005-07-28 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Process for producing human serum albumin by heating in presence of divalent cation
|
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
DK2330200T3
(en)
|
2004-12-23 |
2017-07-24 |
Albumedix As |
GENE EXPRESSION TECHNIQUE
|
|
CA2599731A1
(en)
*
|
2005-03-03 |
2006-09-08 |
Dmi Biosciences, Inc. |
Quantification of proteins
|
|
US7598700B2
(en)
*
|
2005-03-30 |
2009-10-06 |
Reserve Power Cell, Llc |
Tamper resistant battery and battery warranty and performance tracking system
|
|
MY144344A
(en)
*
|
2005-04-08 |
2011-09-15 |
Ciba Holding Inc |
Adsorbents comprising anthraquinone dye-ligands for the separation of biological materials
|
|
DE102005023155A1
(de)
*
|
2005-05-13 |
2006-11-16 |
Albutec Gmbh |
Albuminlösung
|
|
US8323666B2
(en)
|
2005-08-01 |
2012-12-04 |
Allergan, Inc. |
Botulinum toxin compositions
|
|
GB0518460D0
(en)
*
|
2005-09-09 |
2005-10-19 |
Univ Nottingham Trent |
Protein assay
|
|
DK1989220T3
(da)
|
2006-02-02 |
2012-04-02 |
Trimeris Inc |
HIV-fusionsinhibitorpeptider med forbedrede biologiske egenskaber
|
|
JP2007284425A
(ja)
*
|
2006-03-20 |
2007-11-01 |
Nokodai Tlo Kk |
タンパク質の精製方法
|
|
US8334365B2
(en)
*
|
2006-06-07 |
2012-12-18 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
EP2049560B1
(en)
|
2006-07-13 |
2013-05-15 |
Novozymes Biopharma DK A/S |
Process for preparing particles of proteinaceous material
|
|
DK2046826T3
(da)
|
2006-07-24 |
2011-10-24 |
Biorexis Pharmaceutical Corp |
Exendin-fusionsproteiner
|
|
US10829733B2
(en)
*
|
2007-01-04 |
2020-11-10 |
Biolamina Ab |
Composition and method for enabling proliferation of pluripotent human stem cells
|
|
BRPI0809995A2
(pt)
*
|
2007-04-03 |
2015-07-21 |
Trimeris Inc |
Composição, e, métodos para a liberação prolongada de um peptídeo em um paciente e para melhorar um sintoma associado com uma infecção por hiv
|
|
CN101104635B
(zh)
*
|
2007-04-30 |
2010-11-03 |
北京济普霖生物技术有限公司 |
一种从转基因牛乳中纯化重组人α-乳清白蛋白的方法
|
|
JP2010535484A
(ja)
|
2007-08-08 |
2010-11-25 |
ノボザイムス バイオファーマ デーコー アクティーゼルスカブ |
トランスフェリン変異体と複合体
|
|
JP2010540528A
(ja)
*
|
2007-09-25 |
2010-12-24 |
トリメリス，インコーポレーテッド |
治療的抗ウイルス性ペプチドの新規合成方法
|
|
CN101978268B
(zh)
*
|
2008-03-31 |
2014-04-23 |
积水医疗株式会社 |
纯化血清白蛋白及免疫学测定方法
|
|
CN102026648A
(zh)
*
|
2008-05-15 |
2011-04-20 |
株式会社·R-技术上野 |
用于治疗干眼和/或角膜结膜损伤的药物组合物
|
|
JP5856843B2
(ja)
|
2008-05-27 |
2016-02-10 |
アンピオ ファーマシューティカルズ，インコーポレイテッド |
ジケトピペラジンを用いた医薬組成物
|
|
US8420051B2
(en)
|
2008-06-24 |
2013-04-16 |
Technische Universitaet Meunchen |
Muteins of hNGAL and related proteins with affinity for a given target
|
|
CN102317315A
(zh)
|
2009-02-11 |
2012-01-11 |
诺维信生物制药丹麦公司 |
白蛋白变体和缀合物
|
|
JP2012518409A
(ja)
*
|
2009-02-20 |
2012-08-16 |
ベントリア・バイオサイエンス |
タンパク質の組み合わせを含有する細胞培養培地
|
|
DE102009013914B4
(de)
*
|
2009-03-19 |
2011-05-05 |
Bruker Daltonik Gmbh |
Kalibriersubstanzen für Atmosphärendruck-Ionenquellen
|
|
US9403898B2
(en)
*
|
2009-05-07 |
2016-08-02 |
Novozymes Biopharma Dk A/S |
Method for purifying albumin
|
|
CN102612362A
(zh)
|
2009-08-05 |
2012-07-25 |
皮里斯股份公司 |
脂质运载蛋白突变蛋白的控制释放制剂
|
|
NZ598249A
(en)
*
|
2009-08-20 |
2014-04-30 |
Baxter Int |
Purification of vwf for increased removal of non-lipid enveloped viruses
|
|
WO2011051489A2
(en)
|
2009-10-30 |
2011-05-05 |
Novozymes Biopharma Dk A/S |
Albumin variants
|
|
AU2010329995B2
(en)
|
2009-12-07 |
2015-09-17 |
Pieris Ag |
Muteins of human lipocalin 2 (Lcn2, hNGAL) with affinity for a given target
|
|
SG182618A1
(en)
*
|
2010-01-25 |
2012-08-30 |
Ventria Bioscience |
Methods & compositions for improving protein production
|
|
CN102939304B
(zh)
|
2010-04-09 |
2017-04-19 |
阿尔布麦狄克斯公司 |
白蛋白衍生物和变体
|
|
NZ603562A
(en)
|
2010-06-08 |
2014-07-25 |
Pieris Ag |
Tear lipocalin muteins binding il-4 r alpha
|
|
DK2606061T3
(da)
|
2010-08-16 |
2017-11-06 |
Pieris Pharmaceuticals Gmbh |
Bindingsproteiner til hepcidin
|
|
CA2810844C
(en)
|
2010-09-07 |
2017-03-21 |
Dmi Acquisition Corp. |
Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
|
|
WO2012065978A1
(en)
|
2010-11-15 |
2012-05-24 |
Pieris Ag |
Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
|
|
EP2646552B1
(en)
|
2010-12-02 |
2017-07-05 |
Pieris Pharmaceuticals GmbH |
Muteins of human lipocalin 2 with affinity for ctla-4
|
|
PL221899B1
(pl)
|
2011-05-06 |
2016-06-30 |
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną |
Czysta albumina oraz sposób jej otrzymywania i detekcji
|
|
SG10201606161UA
(en)
|
2011-07-05 |
2016-09-29 |
Novozymes Biopharma Dk As |
Albumin Formulation and Use
|
|
EP3701921A1
(en)
|
2011-10-10 |
2020-09-02 |
Ampio Pharmaceuticals, Inc. |
Implantable medical devices with increased immune tolerance, and methods for making and implanting
|
|
CA2846598C
(en)
|
2011-10-10 |
2019-12-10 |
Ampio Pharmaceuticals, Inc. |
Treatment of degenerative joint disease
|
|
SG10201605205VA
(en)
|
2011-10-28 |
2016-08-30 |
Ampio Pharmaceuticals Inc |
Treatment of rhinitis
|
|
WO2013075066A2
(en)
|
2011-11-18 |
2013-05-23 |
Eleven Biotherapeutics, Inc. |
Proteins with improved half-life and other properties
|
|
EP2790719B1
(en)
|
2011-12-13 |
2018-11-21 |
Pieris Pharmaceuticals GmbH |
Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors.
|
|
EP3330283A3
(en)
|
2012-03-16 |
2018-07-11 |
Albumedix A/S |
Albumin variants
|
|
WO2013174783A1
(en)
|
2012-05-23 |
2013-11-28 |
Pieris Ag |
Lipocalin muteins with binding-affinity for glypican-3 (gpc-3) and use of lipocalin muteins for target-specific delivery to cells expressing gpc-3
|
|
US20140031527A1
(en)
*
|
2012-07-27 |
2014-01-30 |
Csl Limited |
Method for polishing albumin
|
|
CN105452290A
(zh)
|
2012-11-08 |
2016-03-30 |
诺维信生物制药丹麦公司 |
白蛋白变体
|
|
US20140186447A1
(en)
*
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
JP6128677B2
(ja)
*
|
2013-02-05 |
2017-05-17 |
公立大学法人大阪市立大学 |
神経細胞の遊走障害を伴う疾患の判定方法及びその利用
|
|
EP2968490A1
(en)
|
2013-03-14 |
2016-01-20 |
Daiichi Sankyo Co., Ltd. |
Novel binding proteins for pcsk9
|
|
US9808454B2
(en)
|
2013-03-15 |
2017-11-07 |
Ampio Pharmaceuticals, Inc. |
Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
|
|
CA2891557A1
(en)
|
2013-03-26 |
2014-05-22 |
Pieris Ag |
Novel specific-binding polypeptides and uses thereof
|
|
CN103694343B
(zh)
*
|
2013-12-26 |
2016-05-25 |
扬州艾迪生物科技有限公司 |
一种从尿液中制备人血白蛋白的方法
|
|
CA2936611A1
(en)
|
2014-01-13 |
2015-07-16 |
Pieris Pharmaceuticals Gmbh |
Multi-specific polypeptide useful for localized tumor immunomodulation
|
|
JP6700197B2
(ja)
*
|
2014-04-30 |
2020-05-27 |
ノヴォ ノルディスク アー／エス |
カプリル酸を用いてタンパク質を精製する方法
|
|
SG11201609274SA
(en)
|
2014-05-22 |
2016-12-29 |
Pieris Pharmaceuticals Gmbh |
Novel specific-binding polypeptides and uses thereof
|
|
EP3183240A4
(en)
|
2014-08-18 |
2018-06-27 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
|
CN104628830A
(zh)
*
|
2015-01-23 |
2015-05-20 |
深圳康泰生物制品股份有限公司 |
重组酿酒酵母表达HBsAg的制备工艺及其分离纯化工艺、HBsAg和乙肝疫苗
|
|
WO2016120307A1
(en)
|
2015-01-28 |
2016-08-04 |
Pieris Ag |
Novel proteins specific for angiogenesis
|
|
CN107660211A
(zh)
|
2015-02-18 |
2018-02-02 |
赛诺菲 |
新的对绿脓菌荧光素和绿脓菌螯铁蛋白特异性的蛋白质
|
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
|
RU2727165C2
(ru)
|
2015-05-04 |
2020-07-21 |
ПИЕРИС ФАРМАСЬЮТИКАЛС ГмбХ |
Слитый полипептид с противораковой активностью
|
|
CN114573680A
(zh)
|
2015-05-04 |
2022-06-03 |
皮里斯制药有限公司 |
Cd137特异性的蛋白
|
|
US10273275B2
(en)
|
2015-05-18 |
2019-04-30 |
Pieris Pharmaceuticals Gmbh |
Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof
|
|
RS64002B1
(sr)
|
2015-05-18 |
2023-03-31 |
Pieris Pharmaceuticals Gmbh |
Anti-kancerski fuzioni polipeptid
|
|
US11389512B2
(en)
|
2015-06-22 |
2022-07-19 |
Ampio Pharmaceuticals, Inc. |
Use of low molecular weight fractions of human serum albumin in treating diseases
|
|
EP3115371A1
(en)
|
2015-07-07 |
2017-01-11 |
Sanofi |
Fusion molecules
|
|
MX2018000447A
(es)
|
2015-07-15 |
2018-08-15 |
Pieris Pharmaceuticals Gmbh |
Novedosas proteinas especificas para lag-3.
|
|
US10633428B2
(en)
|
2015-08-20 |
2020-04-28 |
Albumedix Ltd |
Albumin variants and conjugates
|
|
FR3040882A1
(fr)
*
|
2015-09-10 |
2017-03-17 |
Lab Francais Du Fractionnement |
Composition liquide d'albumine humaine a usage therapeutique
|
|
US10703810B2
(en)
|
2015-11-30 |
2020-07-07 |
Pieris Australia Pty Ltd. |
Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)
|
|
TW201725212A
(zh)
|
2015-12-10 |
2017-07-16 |
第一三共股份有限公司 |
特異性於降鈣素基因相關胜肽的新穎蛋白
|
|
JP7146637B2
(ja)
|
2015-12-22 |
2022-10-04 |
アルブミディクス リミティド |
改善されたタンパク質発現株
|
|
CN108431204A
(zh)
|
2015-12-22 |
2018-08-21 |
阿尔布梅迪克斯医疗有限公司 |
改良的表达蛋白质的菌株
|
|
KR102050852B1
(ko)
*
|
2016-03-11 |
2019-12-03 |
주식회사 스템온 |
세포 리프로그래밍 장치
|
|
CN110198952B9
(zh)
*
|
2016-08-17 |
2024-05-28 |
勃林格殷格翰国际公司 |
制备含有生物分子的高度浓缩的液体制剂的方法
|
|
JP6928084B2
(ja)
|
2016-10-04 |
2021-09-01 |
アルブミディクス リミティド |
組換え酵母由来血清アルブミンの使用
|
|
WO2018087108A1
(en)
|
2016-11-09 |
2018-05-17 |
Pieris Pharmaceuticals Gmbh |
Proteins specific for cd137
|
|
EP3571219A1
(en)
|
2017-01-18 |
2019-11-27 |
Pieris Pharmaceuticals GmbH |
Lipocalin muteins with binding affinity for lag-3
|
|
CN110678481B
(zh)
*
|
2017-03-16 |
2023-10-31 |
伊沃芙生物制品公司 |
用于纯化白蛋白的方法
|
|
ES2906997T3
(es)
|
2017-06-20 |
2022-04-21 |
Albumedix Ltd |
Cepas de expresión de proteínas mejoradas
|
|
MX2020010724A
(es)
*
|
2018-04-12 |
2020-11-06 |
Amgen Inc |
Metodos para preparar composiciones proteicas estables.
|
|
CN110563833A
(zh)
*
|
2018-06-06 |
2019-12-13 |
中国计量科学研究院 |
一种人血白蛋白标准物质原料的制备方法及其产品和应用
|
|
EP4249064A3
(en)
|
2018-07-31 |
2023-12-06 |
Pieris Pharmaceuticals GmbH |
Novel fusion protein specific for cd137 and pd-l1
|
|
CN109734796B
(zh)
*
|
2019-02-01 |
2022-04-15 |
广州蕊特生物科技有限公司 |
一种从溶血血清中分离白蛋白的工艺
|
|
CN109776673B
(zh)
*
|
2019-02-20 |
2022-03-29 |
天津理工大学 |
一种适合中试量产的高纯度牛血清白蛋白纯化工艺
|
|
CN113474359B
(zh)
|
2019-02-26 |
2025-02-21 |
皮里斯制药有限公司 |
对cd137和gpc3特异性的新型融合蛋白
|
|
CN110229229A
(zh)
*
|
2019-07-10 |
2019-09-13 |
甘肃养泰和生物科技有限公司 |
一种从牛血浆中提取纯化细胞培养级牛血清白蛋白的生产方法及其应用
|
|
JP2022553426A
(ja)
|
2019-10-28 |
2022-12-22 |
アブラクシス バイオサイエンス， エルエルシー |
アルブミンおよびラパマイシンの医薬組成物
|
|
AU2021285201A1
(en)
|
2020-06-05 |
2022-11-24 |
Pieris Pharmaceuticals Gmbh |
Multimeric immunomodulator targeting 4-1BB
|
|
US12161777B2
(en)
|
2020-07-02 |
2024-12-10 |
Davol Inc. |
Flowable hemostatic suspension
|
|
US11739166B2
(en)
|
2020-07-02 |
2023-08-29 |
Davol Inc. |
Reactive polysaccharide-based hemostatic agent
|
|
US20230265166A1
(en)
|
2020-08-11 |
2023-08-24 |
Shenzhen Protgen Ltd. |
Young and undamaged human serum albumin improves longevity of human
|
|
KR20230088914A
(ko)
|
2020-10-30 |
2023-06-20 |
선전 프로트젠 엘티디. |
질환 치료에서 인간 혈청 알부민의 응용
|
|
JP7674630B2
(ja)
|
2020-12-08 |
2025-05-12 |
通化安睿特生物製薬股▲フェン▼有限公司 |
組換えタンパク質を精製する方法
|
|
CN112592399B
(zh)
*
|
2020-12-15 |
2024-04-12 |
甘肃养泰和生物科技有限公司 |
一种从牛血清中分离牛血清白蛋白的制备方法及装置
|
|
EP4267210A1
(en)
|
2020-12-28 |
2023-11-01 |
Davol Inc. |
Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
|
|
US20240228562A1
(en)
|
2021-04-08 |
2024-07-11 |
Pieris Pharmaceuticals Gmbh |
Novel lipocalin muteins specific for connective tissue growth factor (ctgf)
|
|
WO2022243341A1
(en)
|
2021-05-18 |
2022-11-24 |
Pieris Pharmaceuticals Gmbh |
Lipocalin muteins with binding affinity for ox40
|
|
CN113735963A
(zh)
*
|
2021-09-10 |
2021-12-03 |
山东健通生物科技有限公司 |
一种重组人血清白蛋白纯化过程去除色素的方法
|
|
CN114316088B
(zh)
*
|
2021-12-22 |
2022-09-09 |
中国水产科学研究院黄海水产研究所 |
亲和树脂、制备方法及其在分离纯化藻蓝蛋白中的应用
|
|
TW202428603A
(zh)
|
2022-09-21 |
2024-07-16 |
美商思進公司 |
新穎的cd137及cd228特異性融合蛋白
|
|
CN115677848A
(zh)
*
|
2022-10-24 |
2023-02-03 |
通化安睿特生物制药股份有限公司 |
一种制备高纯度高稳定性蛋白质的方法
|
|
CN116120392B
(zh)
*
|
2023-04-18 |
2023-08-01 |
上海健士拜生物科技有限公司 |
聚体蛋白的纯化方法
|
|
WO2025175123A1
(en)
|
2024-02-16 |
2025-08-21 |
Seagen Inc. |
Methods of treating cancer using fusion proteins specific for cd137 and cd228
|